Ventricular arrhythmias following balloon-expandable transcatheter pulmonary valve replacement in the native right ventricular outflow tract.
Spencer B BarfussJuan Carlos SamayoaSusan P EtheridgeThomas A PilcherSarah Yukiko AsakiZhining OuDana M BoucekMary Hunt MartinRobert G GrayMary C NiuPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2023)
Though common after balloon-expandable TPVR within the nRVOT, ventricular arrhythmias were benign and transient. Antiarrhythmic medications were successfully discontinued in the majority at 6- to 8-week follow-up, and in all patients by 20 months.
Keyphrases
- end stage renal disease
- heart failure
- left ventricular
- ejection fraction
- catheter ablation
- newly diagnosed
- chronic kidney disease
- prognostic factors
- aortic valve
- pulmonary hypertension
- mitral valve
- clinical trial
- randomized controlled trial
- cerebral ischemia
- transcatheter aortic valve replacement
- patient reported
- subarachnoid hemorrhage